140 related articles for article (PubMed ID: 36214360)
21. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis.
Kabel AM; Arab HH; Abd Elmaaboud MA
Hum Exp Toxicol; 2021 Oct; 40(10):1710-1720. PubMed ID: 33840231
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Hassan HM; El-Kannishy SMH; Alattar A; Alshaman R; Hamdan AM; Al-Gayyar MMH
Biomed Pharmacother; 2021 Mar; 135():111216. PubMed ID: 33433352
[TBL] [Abstract][Full Text] [Related]
23. Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats.
Ibrahim S; Fahim SA; Tadros SA; Badary OA
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23078. PubMed ID: 35437842
[TBL] [Abstract][Full Text] [Related]
24. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
[TBL] [Abstract][Full Text] [Related]
25. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
Mohamed AA; Zaghloul RA; Abdelghany AM; El Gayar AM
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22989. PubMed ID: 35179263
[TBL] [Abstract][Full Text] [Related]
26. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
27. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
28. The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.
Anwar HM; Moghazy AM; Osman AAE; Abdel Rahman AAS
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2153-2163. PubMed ID: 34319038
[TBL] [Abstract][Full Text] [Related]
29. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.
Yi X; Long L; Yang C; Lu Y; Cheng M
PLoS One; 2014; 9(4):e93599. PubMed ID: 24690765
[TBL] [Abstract][Full Text] [Related]
30. Estrogen Attenuates Diethylnitrosamine-Induced Hepatocellular Carcinoma in Female Rats via Modulation of Estrogen Receptor/FASN/CD36/IL-6 Axis.
Abdel-Hamid MS; Mansour AM; Hassan MH; Abdelhady R; Elsadek BEM; El-Sayed EM; Salama SA
Biol Pharm Bull; 2023; 46(11):1558-1568. PubMed ID: 37914358
[TBL] [Abstract][Full Text] [Related]
31. Phytofabricated silver nanoparticles of Phyllanthus emblica attenuated diethylnitrosamine-induced hepatic cancer via knock-down oxidative stress and inflammation.
Singh D; Yadav E; Falls N; Kumar V; Singh M; Verma A
Inflammopharmacology; 2019 Oct; 27(5):1037-1054. PubMed ID: 30219979
[TBL] [Abstract][Full Text] [Related]
32. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats.
Sánchez-Meza J; Campos-Valdez M; Domínguez-Rosales JA; Godínez-Rubí JM; Rodríguez-Reyes SC; Martínez-López E; Zúñiga-González GM; Sánchez-Orozco LV
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176094
[TBL] [Abstract][Full Text] [Related]
33. Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques.
Wei BR; Edwards JB; Hoover SB; Tillman HS; Reed LT; Sills RC; Simpson RM
Toxicol Pathol; 2008 Dec; 36(7):972-80. PubMed ID: 18978308
[TBL] [Abstract][Full Text] [Related]
34. Myricetin Selectively Induces Apoptosis on Cancerous Hepatocytes by Directly Targeting Their Mitochondria.
Seydi E; Rasekh HR; Salimi A; Mohsenifar Z; Pourahmad J
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):249-58. PubMed ID: 26919160
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C.
El Sadda RR; Elshahawy ZR; Saad EA
BMC Cancer; 2023 Feb; 23(1):175. PubMed ID: 36809998
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Medhat A; Mansour S; El-Sonbaty S; Kandil E; Mahmoud M
Tumour Biol; 2017 Jul; 39(7):1010428317717259. PubMed ID: 28720064
[TBL] [Abstract][Full Text] [Related]
37. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
38. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
39. The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.
Abd-Elbaset M; Mansour AM; Ahmed OM; Abo-Youssef AM
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1611-1624. PubMed ID: 32270258
[TBL] [Abstract][Full Text] [Related]
40. Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model.
Nota T; Kageyama K; Yamamoto A; Kakehashi A; Yonezawa H; Jogo A; Sohgawa E; Murai K; Ogawa S; Miki Y
Acad Radiol; 2023 Jan; 30(1):30-39. PubMed ID: 35680546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
